Latest Safety News

Qoria Limited reports robust December quarter results for FY2025, driven by strong ARR growth, expanding global reach, and strategic AI innovations that promise to accelerate future growth.

Liontown Resources has reported a robust December 2024 quarter at its Kathleen Valley Lithium Operation, delivering strong production and financial results that underscore its trajectory towards becoming a world-class lithium producer.

Hillgrove Resources delivered a robust December quarter with record development and copper production, underpinned by exceptional drilling results at Nugent. The company projects increased output and improved cost efficiency for 2025.

PolyNovo Limited reports a robust 22.8% revenue increase in 1H FY25, driven by strong U.S. and international sales growth and progressing FDA approval efforts for its NovoSorb platform.

Visioneering Technologies reports promising interim results from its PROTECT trial, showing significant control of myopia progression in children using NaturalVue® Multifocal lenses.

Spacetalk Limited reports a robust 12% increase in Annual Recurring Revenue to $11 million, driven by a 21% jump in paid mobile subscribers, signaling strong momentum and international ambitions.

Dimerix has reached a key milestone by enrolling the first paediatric patient aged 12-17 in its ACTION3 Phase 3 trial for DMX-200, advancing its potential treatment for childhood FSGS kidney disease.

Ora Banda Mining reports a robust December quarter, boosting cash reserves to $57.8 million and advancing underground operations at Riverina and Sand King towards a 150koz production target in FY26.

Rio Tinto's Q4 2024 production results reflect steady operational performance with record bauxite output and significant progress on key growth projects like Oyu Tolgoi and Rincon lithium expansion.

Magnetic Resources has significantly increased the gold resource estimate at its Lady Julie Gold Project to 1.75 million ounces, advancing plans for concurrent underground mining and an expanded processing plant.

Anatara Lifesciences has successfully completed recruitment for the second stage of its pivotal GaRP-IBS clinical trial, with headline results expected in Q1 2025. The company also launched a new anti-obesity project and strengthened its cash position through recent capital raises.

Element 25 has obtained key regulatory approval from WA's DEMIRS for its Butcherbird Expansion Project, paving the way for a twelve-year production run at 1.1 million tonnes per annum of manganese concentrate. The final hurdle remains the Works Approval, expected imminently.